CC
Callan Capital Portfolio holdings
AUM
$1.35B
1-Year Return
8.35%
This Quarter Return
+7.05%
1 Year Return
+8.35%
3 Year Return
+20.11%
5 Year Return
+98.58%
10 Year Return
+94.69%
AUM
$1.14B
AUM Growth
+$78M
(+7.4%)
Cap. Flow
+$567K
Cap. Flow
% of AUM
0.05%
Top 10 Holdings %
Top 10 Hldgs %
49.37%
Holding
304
New
70
Increased
124
Reduced
70
Closed
7
Top Buys
| 1 |
Avantis US Small Cap Value ETF
AVUV
|
$4.17M |
| 2 |
Vanguard Tax-Exempt Bond Index Fund
VTEB
|
$3.92M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
$3.04M |
| 4 |
Neumora Therapeutics
NMRA
|
$2.82M |
| 5 |
Microsoft
MSFT
|
$2.54M |
Top Sells
| 1 |
NVIDIA
NVDA
|
$19.9M |
| 2 |
Schwab US Broad Market ETF
SCHB
|
$6.15M |
| 3 |
JPMorgan Ultra-Short Municipal Income ETF
JMST
|
$3.04M |
| 4 |
Schwab International Equity ETF
SCHF
|
$2.54M |
| 5 |
Edwards Lifesciences
EW
|
$2.12M |
Sector Composition
| 1 | Technology | 5.18% |
| 2 | Healthcare | 2.32% |
| 3 | Financials | 1.59% |
| 4 | Consumer Discretionary | 1.18% |
| 5 | Communication Services | 1.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
JPMorgan Ultra-Short Income ETF
JPST
$33B
| – | – |
-18,784
| Closed | -$944K |
|
302
SPDR S&P Biotech ETF
XBI
$5.24B
| – | – |
-3,958
| Closed | -$353K |
|
|
EFTR
303
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| – | – |
-800
| Closed | -$9.35K |
|
|
MRTX
304
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| – | – |
-6,431
| Closed | -$378K |
|